If patients don’t respond to capsaicin patches for neuropathic pain, try again

Reuters Health - 02/10/2020 - Patients with peripheral neuropathic pain who don't initially respond to capsaicin patches may end up responding later. That's according to a post-hoc analysis of two 52-week studies presented virtually at the PAINWeek 2020 virtual conference from September 11-13. "Although at month 12, the responder rates in patients who did not initially respond to HCCP were approximately 10% lower than in the overall population, the substantial increase in responder rates . . . justifies a repeat treatment," Dr. Rainer Freynhagen of Benedictus Hospital Tutzing in Tutzing, Germany, and colleagues write in their conference abstract. The researchers analyzed two studies on capsaicin 8% patches. The observational STRIDE trial (https://bit.ly/36q0M3d), published in 2017, included 306 patients with nondiabetic peripheral neuropathic pain. The 2019 PACE randomized controll...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 2 October, 202022 October, 2020